---
title: "Salubris: The application for listing of Tislelizumab injection has been accepted"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/258071062.md"
description: "According to the Zhitong Finance APP, Salubris announced that the company's subsidiary, Salubris (Suzhou) Pharmaceutical Co., Ltd., has submitted a listing application for its independently developed Class 1 biological drug \"Ticagrelor Injection,\" which has been accepted by the National Medical Products Administration. The intended indications are: hypercholesterolemia and mixed dyslipidemia"
datetime: "2025-09-19T10:59:02.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/258071062.md)
  - [en](https://longbridge.com/en/news/258071062.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/258071062.md)
generator: "portal-rs"
---

# Salubris: The application for listing of Tislelizumab injection has been accepted

According to the Zhitong Finance APP, Salubris (002294.SZ) announced that the company's subsidiary, Salubris (Suzhou) Pharmaceutical Co., Ltd., has submitted a listing application for its independently developed Class 1 biological drug "Takasimab Injection," which has been accepted by the National Medical Products Administration. The intended indications are: hypercholesterolemia and mixed dyslipidemia

### Related Stocks

- [002294.CN](https://longbridge.com/en/quote/002294.CN.md)

## Related News & Research

- [Vishnusurya Projects and Infra's (NSE:VISHNUINFR) Weak Earnings May Only Reveal A Part Of The Whole Picture](https://longbridge.com/en/news/305559929.md)
- [Pondy Oxides And Chemicals Limited Just Missed Earnings And Its Revenue Numbers Were Weaker Than Expected](https://longbridge.com/en/news/305560101.md)
- [Alkem Laboratories Limited (NSE:ALKEM) Just Released Its Second-Quarter Results And Analysts Are Updating Their Estimates](https://longbridge.com/en/news/305559747.md)
- [RioCan Real Estate Investment Trust (TSX:REI.UN) Expands Its Buyback Program, Is It Still Undervalued?](https://longbridge.com/en/news/305557624.md)
- [Kava Lend loses roughly $3.8 million to hack, sending KAVA token down nearly 40%](https://longbridge.com/en/news/305556359.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**